anti-vitamin B12 receptor expression siRNAs (Kyto)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-vitamin B12 receptor expression siRNAs (Kyto)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionVitamin B12 modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyto Technology and Life Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyto Technology and Life Science Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A